Hormone replacement therapy and endometrial cancer risk: A meta-analysis
Endometrial cancer risk increases substantially with long duration of unopposed estrogen use, and this increased risk persists for several years after discontinuation of estrogen.
Meta Analysis
1 effect
10 years